Showing results (11-20 of 75) with videos related to
Sort By:
Pageof 8
Pure and Applied Chemistry. Chimie Pure Et Appliquee|January 3, 2015
New strategies for natural products containing chroman spiroketalsJason C Green, G Leslie Burnett, Thomas R R PettusData in Brief|July 18, 2025
A dataset of estimated heterozygous individual and carrier couple frequencies for pan-ancestry carrier screeningMia J Gruzin, Matthew Hobbs, Sarah Poll, et al.The Application of Clinical Genetics|February 6, 2015
Tay-Sachs disease: current perspectives from AustraliaRaelia M Lew, Leslie Burnett, Anné L Proos, et al.Journal of the American Chemical Society|August 29, 2015
Synthesis of Hindered α-Amino Carbonyls: Copper-Catalyzed Radical Addition with Nitroso CompoundsDavid J Fisher, G Leslie Burnett, Rocío Velasco, et al.Australian Family Physician|June 14, 2017
Up, up and away: The growth of after-hours MBS claimsBarbara de Graaff, Mark Nelson, Amanda NeilJournal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|June 1, 2026
Ensuring equity in reproductive carrier screening of CFTR with increasing population diversityMia J Gruzin, Jaysen Knezovich, Sarah Poll, et al.Journal of Evaluation in Clinical Practice|October 24, 2024
Use and impact of clinical pathways across various healthcare settings: A protocol for an umbrella review of global evidenceRishita Chandra, Maria Unwin, Viet Tran, et al.The Journal of Organic Chemistry|January 22, 2011
A strategy for the late-stage divergent syntheses of scyphostatin analoguesJacob Y Cha, G Leslie Burnett, Yaodong Huang, et al.Journal of Clinical Immunology|June 3, 2020
The Clinical Immunogenomics Research Consortium Australasia (CIRCA): a Distributed Network Model for Genomic Healthcare DeliveryTri Giang Phan, Paul E Gray, Melanie Wong, et al.The Medical Journal of Australia|December 13, 2012
Tay Sachs disease in Australia: reduced disease incidence despite stable carrier frequency in Australian JewsRaelia M Lew, Anne L Proos, Leslie Burnett, et al.Pageof 8